Therefore, to restore the balance of histone acetylation levels and reduce cell damage in PD, HAT inhibitors or selective inhibitors targeting HDAC2, HDAC3, or HDAC4 are preferable to nonspecific HDAC inhibitors.323. Here, HDAC9 is linked to Parkinson disease.